327 related articles for article (PubMed ID: 22648570)
1. Diffusion-weighted magnetic resonance imaging in the characterization of axillary lymph nodes in patients with breast cancer.
Fornasa F; Nesoti MV; Bovo C; Bonavina MG
J Magn Reson Imaging; 2012 Oct; 36(4):858-64. PubMed ID: 22648570
[TBL] [Abstract][Full Text] [Related]
2. Apparent diffusion coefficient ratio between axillary lymph node with primary tumor to detect nodal metastasis in breast cancer patients.
Luo N; Su D; Jin G; Liu L; Zhu X; Xie D; Liu Y
J Magn Reson Imaging; 2013 Oct; 38(4):824-8. PubMed ID: 23440958
[TBL] [Abstract][Full Text] [Related]
3. Discrimination of axillary metastatic from nonmetastatic lymph nodes with PROPELLER diffusion-weighted MR imaging in a metastatic breast cancer model and its correlation with cellularity.
Junping W; Tongguo S; Yunting Z; Chunshui Y; Renju B
J Magn Reson Imaging; 2012 Sep; 36(3):624-31. PubMed ID: 22570219
[TBL] [Abstract][Full Text] [Related]
4. Detection of axillary node metastasis using diffusion-weighted MRI in breast cancer.
Kamitani T; Hatakenaka M; Yabuuchi H; Matsuo Y; Fujita N; Jinnouchi M; Nagao M; Shirahane K; Tokunaga E; Honda H
Clin Imaging; 2013; 37(1):56-61. PubMed ID: 23206608
[TBL] [Abstract][Full Text] [Related]
5. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
[TBL] [Abstract][Full Text] [Related]
6. Assessment of axillary lymph nodes in patients with breast cancer with diffusion-weighted MR imaging in combination with routine and dynamic contrast MR imaging.
Razek AA; Lattif MA; Denewer A; Farouk O; Nada N
Breast Cancer; 2016 May; 23(3):525-32. PubMed ID: 25763535
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of diffusion-weighted MRI with STIR-EPI in differential diagnosis of cervical lymph nodes].
Zhang Y; Liang BL; Gao L; Zhong JL; Ye RX; Shen J
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):70-3. PubMed ID: 17575700
[TBL] [Abstract][Full Text] [Related]
8. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes.
Holzapfel K; Duetsch S; Fauser C; Eiber M; Rummeny EJ; Gaa J
Eur J Radiol; 2009 Dec; 72(3):381-7. PubMed ID: 18995981
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study.
Schipper RJ; Smidt ML; van Roozendaal LM; Castro CJ; de Vries B; Heuts EM; Keymeulen KB; Wildberger JE; Lobbes MB; Beets-Tan RG
Invest Radiol; 2013 Mar; 48(3):134-9. PubMed ID: 23262788
[TBL] [Abstract][Full Text] [Related]
10. Diffusion weighted images of metastatic as compared with nonmetastatic axillary lymph nodes in patients with newly diagnosed breast cancer.
Yamaguchi K; Schacht D; Nakazono T; Irie H; Abe H
J Magn Reson Imaging; 2015 Sep; 42(3):771-8. PubMed ID: 25556886
[TBL] [Abstract][Full Text] [Related]
11. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging.
Vandecaveye V; De Keyzer F; Vander Poorten V; Dirix P; Verbeken E; Nuyts S; Hermans R
Radiology; 2009 Apr; 251(1):134-46. PubMed ID: 19251938
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of unenhanced MR imaging in the detection of axillary lymph node metastasis: study of reproducibility and reliability.
Scaranelo AM; Eiada R; Jacks LM; Kulkarni SR; Crystal P
Radiology; 2012 Feb; 262(2):425-34. PubMed ID: 22143924
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis value of 3.0 T diffusion-weighted imaging with background suppression magnetic resonance for metastatic lymph nodes in rectal cancer].
Zhuang XZ; Yu SP; Cui J; Chen CQ; Zhao XJ; Pan BT; Li ZP
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Nov; 14(11):842-5. PubMed ID: 22116716
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: early experience.
Kim JK; Kim KA; Park BW; Kim N; Cho KS
J Magn Reson Imaging; 2008 Sep; 28(3):714-9. PubMed ID: 18777531
[TBL] [Abstract][Full Text] [Related]
16. [Differentiation of axillary inflammatory and metastatic lymph nodes with diffusion-weighted imaging in animal modes].
Bai X; Liao Q; Wang JP; Bai RJ; Sun HR; Yu CS; Zhang YT
Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(9):592-5. PubMed ID: 22800945
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of diffusion-weighted (DW) MRI with background signal suppression (MR-DWIBS) in diagnosis of mediastinal lymph node metastasis of nonsmall-cell lung cancer (NSCLC).
Xu L; Tian J; Liu Y; Li C
J Magn Reson Imaging; 2014 Jul; 40(1):200-5. PubMed ID: 24923480
[TBL] [Abstract][Full Text] [Related]
18. Comparison between malignant and benign abdominal lymph nodes on diffusion-weighted imaging.
Akduman EI; Momtahen AJ; Balci NC; Mahajann N; Havlioglu N; Wolverson MK
Acad Radiol; 2008 May; 15(5):641-6. PubMed ID: 18423322
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of diffusion-weighted magnetic resonance imaging: differentiation of benign and malignant lymph nodes in different regions of the body.
Seber T; Caglar E; Uylar T; Karaman N; Aktas E; Aribas BK
Clin Imaging; 2015; 39(5):856-62. PubMed ID: 26091745
[TBL] [Abstract][Full Text] [Related]
20. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient.
Nakayama J; Miyasaka K; Omatsu T; Onodera Y; Terae S; Matsuno Y; Cho Y; Hida Y; Kaga K; Shirato H
J Comput Assist Tomogr; 2010 Jan; 34(1):1-8. PubMed ID: 20118713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
